Resources

Collateral

  • Collateral

    Lab Outreach Select™ Overview Brochure

    Accumen’s new Lab Outreach Select™ provides hospitals and health systems flexible, customizable solutions to driver performance excellence, maximize profitability, and facilitate the continuum of care.

    Read More
  • Collateral

    PBM Select: Available to Meet Every Program at its Point of Need

    Accumen’s. PBM SelectTM is a customizable approach to help your hospital or health system’s current patient blood management program as you look to reduce cost and improve patient outcomes. This overview provides detailed descriptions on what our components, Performance, Knowledge, and Analytics offer.

    Read More
  • Collateral

    2018 Relative Value Unit System™ Guidelines and Suggestions for Use

    The 2018 Relative Value Unit System™ Guidelines provides an overview including unique features, examples of test complexity, and selected CPT codes with weighted relative value units.

    Read More
  • Collateral

    Accumen Performance Suite™ Technology Delivery Model

    This delivery model provides an overview of The Accumen Performance Suite™ which is a proprietary SaaS solution that provides real-time, actionable insights synthesized and derived from disparate data sources across your health system. HIPAA Compliant and HITRUST Certified.

    Read More
  • APS Technology
    Collateral

    Accumen Performance Suite™ a Purpose-Built Technology Designed by Lab Professionals for Lab Professionals

    The Accumen Peformance Suite™ is a proprietary SaaS solution that provides real-time, actionable insights synthesized and derived from disparate data sources across your health system. This is an ideal pairing of technology with Accumen’s proven approach of assisting hospital/health systems achieve measurable performance improvement for the clinical laboratory and collaborative departments.

    Read More
  • Collateral

    A Prescription for PAMA Reimbursement Cuts-The Facts and Strategies for Reducing Impact

    As 2018 begins with clinical lab rates being reduced by PAMA legislation, we expect Medicare Part B reimbursement for lab testing to decline by approximately 10% this year. However, further rate reductions beyond 2018 are speculative at this time, as efforts to change and/or delay the law continue to escalate. Download this resource for more…

    Read More
  • Collateral

    Test Utilization Management: Measure the Impact for Better Patient Care Overview

    The primary goal of any Test Utilization (TU) program includes ordering the right test, for the right patient, at the right time during the initial evaluation and on-going testing, using evidence-based standards that lead to fewer errors and better patient care.

    Read More
  • Collateral

    Accumen – Company Overview

    Founded in 2011, Accumen partners with health systems to set new standards of performance in the hospital – performance that drives higher quality, better service and unprecedented value. Accumen also supports health systems making the shift toward value-based and patient-centric care through an innovative customized approach and proprietary technology. Download Now

    Read More